Comparison |
| Alternate Manufacturer Number |
1249564 | | 2662757 | 2054724 | |
| Container Type |
Single-Dose Vial | Prefilled Syringe | Prefilled Syringe | Pouch | Prefilled Syringe |
| Country of Origin |
Unknown | Unknown | India | Unknown | Unknown |
| Dosage Form |
Injection | Injection | Injection | Patch | Injection |
| Generic Drug Code |
11251 | 11254 | 11254 | 15524 | 24471 |
| Generic Drug Name |
Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | Norelgestromin / Ethinyl Estradiol | Medroxyprogesterone Acetate |
| NDC Number |
00703680104 | 00009737611 | 55150033001 | 00378334053 | 00009470913 |
| Product Dating |
| McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Quantity |
| | | 3 Patches | |
| Strength |
150 mg / mL | 150 mg / mL | 150 mg / mL | 150 mcg - 35 mcg / 24 Hour | 104 mg / 0.65 mL |
| Type |
Intramuscular | Intramuscular | Intramuscular | Transdermal | Subcutaneous |
| UNSPSC Code |
51351612 | 51351612 | 51351509 | 51352414 | 51351612 |
| Volume |
1 mL | 1 mL | 1 mL | | 0.65 mL |
| Application |
Contraceptive Agent | Contraceptive Agent | Contraceptive Agent | Contraceptive Agent | Contraceptive Agent |
| Features and Benefits |
- Generic Equivalent to Depo-Provera®
- Medroxyprogesterone Acetate Injectable Suspension is indicated only for the prevention of pregnancy
- 25 single dose vials per carton
|
- Depo-Provera CI is a progestin indicated only for the prevention of pregnancy
- The recommended dose is 150 mg of Depo-Provera CI every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle
- Prefilled syringes packaged with 22-gauge x 1-1/2 inch Terumo® SurGuard™ needles
- Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP]
|
|
|
- depo-subQ provera 104 must be given by subcutaneous injection into the anterior thigh or abdomen, once every 3 months (12 to 14 weeks)
- depo-subQ provera 104 is not formulated for intramuscular injection
- The pre-filled syringe of depo-subQ provera 104 must be vigorously shaken just before use to create a uniform suspension
- Supplied as a pre-filled syringe, packaged with a 26-gauge x 3/8 inch Terumo® Surguard™ needle
- Store at controlled room temperature 20º to 25º C (68º to 77ºF)
|
